Back to Trials
NCT04028531Recruiting

Understanding Chronic Lymphocytic Leukemia

Dana-Farber Cancer Institute

Start Date

9/29/1999

Completion Date

9/29/2032

Summary

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Detailed Description

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * New and existing patients seen for treatment of monoclonal B-cell lymphocytosis * Any low grade lymphoproliferative disorder * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere Exclusion Criteria: \-

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Chronic Lymphocytic Leukemia

Locations

Dana Farber Cancer Institute

Boston, Massachusetts 02115

United States